Positive Study Results, CSR Activities, and New Aircraft Livery - Research Reports on Puma Biotechnology, HCA Holdings, United Technologies, Boeing and Caterpillar

NEW YORK, October 1, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Puma Biotechnology, Inc. (NYSE: PBYI), HCA Holdings, Inc. (NYSE: HCA), United Technologies Corporation (NYSE: UTX), The Boeing Company (NYSE: BA) and Caterpillar Inc. (NYSE: CAT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6886-100free.

--
Puma Biotechnology, Inc. Research Reports
On September 29, 2014, Puma Biotechnology, Inc. (Puma Biotechnology) announced positive initial results from the ongoing Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with non-small cell lung cancer (NSCLC) with HER2 mutations. In the trial, patients with confirmed stage IIIB or stage IV NSCLC with documented somatic HER2 mutations were randomized to receive either oral neratinib monotherapy or the combination of oral neratinib with intravenous temsirolimus. According to the Company, the results of the study showed that the combination of PB272 and temsirolimus had acceptable tolerability. "We are pleased with the initial results of the Phase II trial with neratinib in patients with HER2 mutated non- small cell lung cancer," said Alan H. Auerbach, CEO and President. The Company presented the data in an oral presentation titled "Neratinib with or without temsirolimus in patients with non-small cell lung cancer carrying HER2 somatic mutations: An international randomized Phase II study" at the ESMO 2014 Congress. The full research reports on Puma Biotechnology are available to download free of charge at:

http://www.analystsreview.com/Oct-01-2014/PBYI/report.pdf

--
HCA Holdings, Inc. Research Reports
On September 25, 2014, HCA Holdings, Inc. (HCA) announced a cash donation of $1 million to CDC Foundation's Global Disaster Response Fund for supporting international Ebola epidemic response efforts involving the U.S. Centers for Disease Control and Prevention (CDC) and their work with partners on the ground in West Africa. R. Milton Johnson, President and CEO of HCA, commented, "Ebola continues to spread rapidly in West Africa, and CDC and others have made it clear that the window of opportunity to contain the virus is closing quickly. The time to act is now, and we strongly encourage other companies, particularly those in the healthcare industry, to join us in this important effort to save lives." The full research reports on HCA Holdings are available to download free of charge at:

http://www.analystsreview.com/Oct-01-2014/HCA/report.pdf

--
United Technologies Corporation Research Reports
On September 25, 2014, United Technologies Corporation (United Technologies) reported participation by its employees in the U.S., China and India in about 20 projects from September 18 to October 1, 2014, as part of this year's Green Apple Day of Service. The Company stated that these events are designed to transform schools into healthy, safe and productive learning environments. According to United Technologies, this is the third year that UTC employees will participate in the Green Apple Day of Service, which was created by U.S. Green Building Council's (USGBC) Center for Green Schools in 2012. The event kicked off in Jiangxi, China with Carrier employees renovating the playground and restrooms, and painting school walls at the Dafan Central School, and will conclude in October with a clean-up activity at the Government Model Primary School in Bangalore. The full research reports on United Technologies are available to download free of charge at:

http://www.analystsreview.com/Oct-01-2014/UTX/report.pdf

--
The Boeing Company Research Reports
On September 28, 2014, The Boeing Company (Boeing) reported the unveiling of its first 787-9 Dreamliner to be delivered to Etihad Airways. The Company stated that the airplane is painted in the airline's new 'Facets of Abu Dhabi' livery with colors reminiscent of the desert landscape, inspired by the culture, Islamic design and architecture motifs of the United Arab Emirates. Etihad Airways is due to take delivery of its first 787-9 later this year. Boeing Commercial Airplanes President and CEO Ray Conner commented, "Etihad Airways is one of the most forward-thinking airlines of the world and we're proud to have their trust and confidence in the Dreamliner. The airline's new livery is a unique design that reflects the UAE's rich heritage of innovation and great hospitality." The full research reports on Boeing are available to download free of charge at:

http://www.analystsreview.com/Oct-01-2014/BA/report.pdf

--
Caterpillar Inc. Research Reports
On September 25, 2014, Caterpillar Inc. (Caterpillar) reported that the Company, along with the Caterpillar Foundation, is making a $2.5 million investment in The Global Poverty Project (GPP) to support growing the Global Citizen grassroots movement around the world to end extreme poverty by 2030. The aim of Global Poverty Project is to raise awareness and inspire action on the issue of extreme poverty worldwide at the grassroots level. According to the Company, this investment will support advocacy and public policy work around the world to enable entrepreneurship, especially for women, by removing barriers caused by poor and inequitable access to sanitation and lack of access to basic education. Caterpillar Foundation President Michele Sullivan, stated, "Our investment with The Global Poverty Project will help people fulfill their potential, lifting themselves and their communities out of poverty." The full research reports on Caterpillar are available to download free of charge at:

http://www.analystsreview.com/Oct-01-2014/CAT/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review